|Issuer:||KURA ONCOLOGY, INC. (KURA)|
|Original Submission Date:|
PARKS DIANE L.
C/O KURA ONCOLOGY, INC.
12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO, CA 92130
|Title of Security||Transaction Date||2a. Deemed Execution Date||Transaction Code||Shares||Acquired or Disposed||Price per share||5. Amount of Securities Beneficially Owned Following Reported Transaction||6. Ownership Form Direct or Indirect||Nature of Indirect Ownership|
|Title of Derivative Security||Conversion or Exercise Price of Derivative Security||Transaction Date||Deemed Execution Date||Transaction Code||Number of Derivative Securities Acquired (A) or Disposed of (D)||Date Exercisable||Expiration Date||Title and Amount of Securities Underlying Derivative Security||Price of Derivative Security||Number of derivative Securities Beneficially Owned Following Reported Transaction(s)||Ownership Form: Direct (D) or Indirect (I)||Nature of Indirect Beneficial Ownership|
|OPTION TO PURCHASE COMMON STOCK||14.84||2022-06-21||deemed execution date||A||23,000 (a)||2032-06-20||common stock 23,000||$14.84||23,000||direct|
|f1||this option vests in full on the one year anniversary of the date of grant.|